ShortSide Research
Short-Selling Research & Analysis Tools
Rubico is one to avoid despite a 32% premarket jump to $0.93, given delisting risk. Its 0.5-share-per-share stock dividend is going ex-dividend, so corporate-action adjustments explain much of the quoted gap; the shares are hard to borrow and carry high squeeze risk. x.comÂ
JBDI's low float makes its run vulnerable to a dump at some point today, even though it may still have room to rise. Cobra Trading has shares available to short. x.comÂ
C3is trades far below its cash: about $48M on the books against a float of roughly 1.5-2 million shares implies $24-32 a share, yet the stock is near $1.5, and the company is now profitable. It was a dilution machine while acquiring its fleet, but the story looks to be changing. Short interest is 55%, cost to borrow 146%, few shares remain to short, and institutional ownership rose. About 450,000-500,000 warrants at $1.51 and $2.44 remain, making $2.44 the next target. x.com x.com x.com x.com … Show more
Rising Dragon Acquisition, Yunji and Tenon Medical are shorting opportunities because nothing but low float and momentum is holding them up. All three are top gainers with no news or filings. Premarket traders build momentum, retail chases the stock higher, and early buyers then take profits, reversing the move. Shorting no-news top gainers has an excellent success rate over time. x.comÂ
